| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/16/2009 | CA2702024A1 Glucoamylase variants with altered properties |
| 04/16/2009 | CA2702019A1 Glucoamylase variants |
| 04/16/2009 | CA2702005A1 Compositions and methods for use for antobodies against sclerostin |
| 04/16/2009 | CA2701948A1 Hiv preventive vaccine based on hiv specific antibodies |
| 04/16/2009 | CA2701923A1 Assembly of large nucleic acids |
| 04/16/2009 | CA2701788A1 Humanized antibody |
| 04/16/2009 | CA2701677A1 Cho-k1 cell line |
| 04/16/2009 | CA2701646A1 Protein expression from multiple nucleic acids |
| 04/16/2009 | CA2701369A1 Modified growth hormone polypeptides |
| 04/16/2009 | CA2640985A1 Reagents and methods for detecting neisseria gonorrhoeae |
| 04/15/2009 | EP2048505A2 Method for early recognition of the seroconversion of an antibody to hepatitis C |
| 04/15/2009 | EP2048502A1 Method of confirming the specimen-detecting activity of microparticles |
| 04/15/2009 | EP2048247A1 Method for production of pcr amplification product and use thereof |
| 04/15/2009 | EP2048246A1 Method for obtaining oligonucleotide |
| 04/15/2009 | EP2048237A1 Replication deficient Influenza virus for the expression of heterologous sequences |
| 04/15/2009 | EP2048236A1 Gene expression technique |
| 04/15/2009 | EP2048235A2 Synthetic Mammalian Alpha-N-Acetylglucosaminidase and Genetic Sequences Encoding Same |
| 04/15/2009 | EP2048234A1 Chromatographic method for purification of albumin |
| 04/15/2009 | EP2048233A1 MUTANT SepRS, AND METHOD FOR SITE-SPECIFIC INTRODUCTION OF PHOSPHOSERINE INTO PROTEIN BY USING THE SAME |
| 04/15/2009 | EP2048232A1 Non-replicating paramyxoviridae virus vector |
| 04/15/2009 | EP2048231A1 Plasmid, transformant, and method for production of 3-carboxymuconolactone |
| 04/15/2009 | EP2048230A1 Cell death inducer |
| 04/15/2009 | EP2048229A1 Human artificial chromosome (hac) vector, and human cell pharmaceutical comprising human artificial chromosome (hac) vector |
| 04/15/2009 | EP2048228A2 Human liver progenitors |
| 04/15/2009 | EP2048162A1 Novel monoclonal antibody and use of the same |
| 04/15/2009 | EP2048160A1 Tumor antigen based on products of the tumor suppressor gene WT1 |
| 04/15/2009 | EP2048159A1 T cell receptor display |
| 04/15/2009 | EP2048158A1 Glycosylated human alpha interferon muteins, method for obtaining them and use |
| 04/15/2009 | EP2048157A1 Polynucleotide encoding the rg1 polypeptide |
| 04/15/2009 | EP2048155A1 Method and means for the production of pharmaceutically active natural products |
| 04/15/2009 | EP2047867A1 ACE2 activation for treatment of heart, lung and kidney disease and hypertension |
| 04/15/2009 | EP2047863A1 Preventive or remedy for inflammatory disease |
| 04/15/2009 | EP2047862A1 Remedy for renal disease |
| 04/15/2009 | EP2047861A1 Lentiviral gene transfer vectors suitable for iterative administration and their medicinal applications |
| 04/15/2009 | EP2047858A1 Combination products for treating cancer |
| 04/15/2009 | EP2047848A1 Method of treating genetic disease caused by nonsense mutation |
| 04/15/2009 | EP2047260A2 Enabling methods to identify allosteric modulators of receptor activity |
| 04/15/2009 | EP2046993A2 Rna silencing compositions and methods for the treatment of huntington's disease |
| 04/15/2009 | EP2046970A1 A method of producing recombinant biological products |
| 04/15/2009 | EP2046965A2 Knockout mice for different genes and their use for gene characterization |
| 04/15/2009 | EP2046964A2 Transducible delivery of nucleic acids by reversible phosphotriester charge neutralization protecting groups |
| 04/15/2009 | EP2046963A2 Promoter expressed in the dehiscence zone of dry fruits |
| 04/15/2009 | EP2046962A2 Dna encoding ring zine-finger protein and the use of the dna in vectors and bacteria and in plants |
| 04/15/2009 | EP2046961A1 Plants defective for soluble starch synthase iv (ssiv) activity, methods for obtaining the same, ans uses thereof |
| 04/15/2009 | EP2046960A1 Process for producing arachidonic acid and/or eicosapentaenoic acid in plants |
| 04/15/2009 | EP2046959A1 Polynucleotides and methods for enhancing salinity tolerance in plants |
| 04/15/2009 | EP2046958A1 Cleavage of bip by subtilase cytotoxin |
| 04/15/2009 | EP2046957A1 Fatty acid desaturases and uses thereof |
| 04/15/2009 | EP2046956A2 Plant superoxide dismutase expression resistant to micro-rna regulation |
| 04/15/2009 | EP2046954A2 NUCLEIC ACID OF FORMULA (I): GIXmGn, OR (II): CIXmCn, IN PARTICULAR AS AN IMMUNE-STIMULATING AGENT/ADJUVANT |
| 04/15/2009 | EP2046953A1 Hybrid promoters |
| 04/15/2009 | EP2046952A1 Means and methods for manipulating sequential phagolysomalcytosolic translocation of mycobacteria, and uses thereof |
| 04/15/2009 | EP2046950A2 Meganuclease variants cleaving a dna target sequence from a rag gene and uses thereof |
| 04/15/2009 | EP2046943A1 Lactic acid bacteria isolated from mother's milk with probiotic activity and inhibitory activity against body weight augmentation |
| 04/15/2009 | EP2046834A1 Monoclonal antibodies against stromal derived factor-1 (sdf-1) |
| 04/15/2009 | EP2046831A2 Novel multivalent immunoglobulins |
| 04/15/2009 | EP2046830A1 Csf3r polypeptides and uses thereof |
| 04/15/2009 | EP2046826A2 Exendin fusion proteins |
| 04/15/2009 | EP2046819A2 Methods of increasing secretion of polypeptides having biological activity |
| 04/15/2009 | EP2046816A1 Cysteine-tagged staphylococcal protein g variant |
| 04/15/2009 | EP2046369A2 Recombinant host for producing l-asparaginase ii |
| 04/15/2009 | EP2046367A2 Albumin fusion proteins |
| 04/15/2009 | EP2046111A2 Plants with enhanced size and growth rate |
| 04/15/2009 | EP2046110A2 Genes encoding chavicol/eugenol synthase from the creosote bush larrea tridentata |
| 04/15/2009 | EP2046109A2 Photosyntheticorganisms and compositions and methods of generating same |
| 04/15/2009 | EP2046108A1 Altering the fatty acid composition of rice |
| 04/15/2009 | EP1945768A4 Modification of flavonoid biosynthesis in plants |
| 04/15/2009 | EP1931390A4 Compositions and methods for treatment of autoimmune disease |
| 04/15/2009 | EP1789167A4 Method of stably producing microporous membrane and use thereof in method of separating and purifying nucleic acid |
| 04/15/2009 | EP1754052A4 Peptide modulators of cellular phenotype and bi-nucleic acid fragment library |
| 04/15/2009 | EP1745129B1 Antibodies against canine pancreatic lipase |
| 04/15/2009 | EP1625229B1 Method and device for removal of organic molecules from biological mixtures |
| 04/15/2009 | EP1616952B1 Method of detecting pancryatic islet amyloid protein mutant gene and nucleic acid probe and kit therefor |
| 04/15/2009 | EP1592392A4 Production of very long chain polyunsaturated fatty acids in oilseed plants |
| 04/15/2009 | EP1580270B1 Gene for increasing grain yield and uses thereof |
| 04/15/2009 | EP1572904B1 Modified bace |
| 04/15/2009 | EP1549736B1 Zymomonas pentose-sugar fermentating strains and uses thereof |
| 04/15/2009 | EP1534844B1 Method for improving corn starch extractability |
| 04/15/2009 | EP1505148B1 Methods of screening for agonistic antibodies |
| 04/15/2009 | EP1497468B1 Cells for detection of influenza and parainfluenza viruses |
| 04/15/2009 | EP1483409B1 Method of error reduction in nucleic acid populations |
| 04/15/2009 | EP1476577B1 Regulated vectors for controlling dna hypermutability in eukaryotic cells |
| 04/15/2009 | EP1456648B1 Automated sample preparation methods and devices |
| 04/15/2009 | EP1417307B1 Oligonucleotide compositions and their use to induce apoptosis |
| 04/15/2009 | EP1390490B1 Muscle-specific expression vectors |
| 04/15/2009 | EP1373506B1 Yeast strain of saccharomyces cerevisiae with functional expression of a glut transporter |
| 04/15/2009 | EP1352085B1 P2y purinergic receptor expression for identifying preneoplastic and neoplastic states |
| 04/15/2009 | EP1334196B1 Genomic fragment of streptococcus suis and clinical uses thereof |
| 04/15/2009 | EP1326969B1 Improved system for regulation of transgene expression |
| 04/15/2009 | EP1325145B1 Adenoviral vectors for gene delivery in skeletal muscle cells or myoblasts |
| 04/15/2009 | EP1257295B1 Factor vii or viia-like molecules |
| 04/15/2009 | EP1255852B9 Immunoassay and diagnostic reagent for malaria |
| 04/15/2009 | EP1212446B1 Viral replicons and viruses dependent on inducing agents |
| 04/15/2009 | EP1203007B1 Nucleic acid ligands to hepatocyte growth factor/scatter factor (hgf/sf) and its receptor c-met |
| 04/15/2009 | EP1141262B1 Subtilase enzymes of the i-s2 sub-group having an additional amino acid residue in an active site loop region |
| 04/15/2009 | EP1092033B1 Improvements in or relating to plants and plant products |
| 04/15/2009 | EP1012267B1 An antisense oligonucleotide preparation method |
| 04/15/2009 | EP0991782B1 Nucleic acid primers and probes for detecting hiv-1 and hiv-2 |
| 04/15/2009 | EP0912766B1 Monitoring hybridization during pcr |
| 04/15/2009 | EP0871780B1 METHODS FOR FULL-LENGTH cDNA CLONING |